-
DDI2–NFE2L1 Protects Cells from Ferroptosis
2026-08-31
The reference study identifies DDI2-mediated activation of NFE2L1 as an adaptive mechanism that restores proteasome function during ferroptotic stress. Its combination of ubiquitin-site proteomics, genetic perturbation, and chemical inhibition shows how disrupting this pathway increases ferroptosis sensitivity and suggests a framework for studying proteostasis-dependent cancer vulnerabilities.
-
Mildronate Lipidoids for Safer mRNA Vaccine Delivery
2026-08-31
A 2024 ACS Nano study developed mildronate-derived cationic lipidoids for low-dose lipid nanoparticles that maintained effective mRNA delivery while reducing local inflammation compared with an SM102-based formulation. In prophylactic and therapeutic B16OVA melanoma models, the mLNP-69 system supported antitumor mRNA vaccination, providing a preclinical framework for balancing transfection efficiency with tolerability.
-
RG108 for Reliable Cell Viability Assays
2026-08-30
Learn how RG108 (SKU A1913) can improve the interpretation and reproducibility of cell viability, proliferation, and cytotoxicity workflows involving DNA methylation. This scenario-based guide covers mechanism, solvent compatibility, dose–time optimization, data interpretation, and practical product selection.
-
Merimepodib (VX-497): A Metabolic Antiviral Lens
2026-08-29
Merimepodib (VX-497) is an IMPDH inhibitor that reveals how guanine nucleotide metabolism shapes lymphocyte function and viral replication. This article focuses on assay interpretation, host-dependency mapping, and practical experimental design using evidence from PEDV research.
-
FPH1 (BRD-6125): Function-First Liver Models
2026-08-28
FPH1 (BRD-6125) supports a function-first strategy for expanding and evaluating human hepatocytes. This article connects proliferation, hepatic maturity, assay design, and the emerging value of controllable gene-expression systems without overstating current evidence.
-
AS1842856 Foxo1 Inhibitor for Metabolic Assays
2026-08-28
AS1842856 enables activity-focused interrogation of Foxo1 in gluconeogenesis, autophagy research, and PI3K-Akt-Foxo1 signaling. This article translates its product characteristics and the KDM4D-MSC study into practical assay workflows, controls, and troubleshooting decisions.
-
Grazoprevir Hydrate: From Protease to Patient Data
2026-08-27
Grazoprevir hydrate is an exceptionally potent HCV NS3/4A protease inhibitor, but its value is best understood through a translational framework linking enzyme assays, genotype-specific replication models, pharmacokinetics, and clinical outcomes.
-
Merimepodib (VX-497) in IMPDH Workflows
2026-08-27
Merimepodib (VX-497) is a practical probe for testing whether guanine nucleotide supply limits lymphocyte growth or viral replication. This workflow translates PEDV host-dependency findings into controlled antiviral, immunology, and oncology assays with rescue controls, orthogonal readouts, and troubleshooting guidance.
-
TRIM21, ERK1/2, and Drug Resistance in Pituitary Adenomas
2026-08-26
The reference study identifies TRIM21 as an E3 ligase that promotes ERK1/2 ubiquitination, phosphorylation, pituitary adenoma cell proliferation, and dopamine-agonist resistance. Its combination of CRISPR screening, biochemical validation, animal studies, and NanoBiT-based drug screening highlights TRIM21 as a mechanistically supported target while positioning Quisinostat as a candidate for further investigation.
-
ECL Western Blotting Substrate: Practical Guide
2026-08-26
ECL Western Blotting Substrate (SKU K2187) is a luminol-based horseradish peroxidase detection reagent for sensitive, nonradioactive protein detection by chemiluminescence. It is intended for HRP-based Western blot workflows using X-ray film or CCD imaging, not for fluorescent or radioisotopic detection.
-
Taltirelin Protects Dopaminergic Neurons in PD Models
2026-08-25
The 2018 Frontiers in Cellular Neuroscience study shows that the long-acting TRH analog Taltirelin protects dopaminergic neurons across cellular, MPTP, and rotenone models of Parkinson’s disease. Its most important contribution is the convergence of reduced oxidative stress and apoptosis with suppression of MAO-B activity and AEP-dependent pathological cleavage of tau and α-synuclein.
-
Diuron: Applied Workflows for Plant and Toxicology
2026-08-25
Use Diuron as both a defined photosynthesis inhibitor for plant biology research and a mechanistic toxicology probe for renal injury studies. This workflow connects solvent handling, dose-response design, pathway-focused assays, and troubleshooting without conflating plant activity with mammalian toxicity.
-
AM 281: Mapping CB1–CREB–GLT-1 Signaling
2026-08-24
AM 281 is a selective CB1 cannabinoid receptor antagonist for dissecting how endocannabinoid signaling influences glutamate homeostasis and cognition after brain injury. This article presents a practical assay framework that connects receptor pharmacology with astrocyte GLT-1 regulation, behavioral testing, and evidence-aware interpretation.
-
2'3'-cGAMP (Sodium Salt) in STING Research
2026-08-24
2'3'-cGAMP is an endogenous cGAS-derived second messenger that activates STING, TBK1, IRF3, and type I interferon induction. The 2'3'-cGAMP (sodium salt) product B8362 provides a defined research reagent for dissecting cGAS-STING signaling, with supplier-listed high-affinity STING binding and water-based formulation guidance.
-
Cisapride in Reliable Cell Assays
2026-08-23
Learn how Cisapride (SKU B1198) can serve as a mechanistic probe and reference compound in viability, proliferation, and cardiotoxicity workflows. This scenario-based guide connects formulation control, hERG biology, 5-HT4 signaling, and high-content phenotyping to more interpretable laboratory data.